CMND
Clearmind Medicine·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform
Technical assessment reveals 1.0/10 overall, depicting challenging technical structure. Constructive developments in no significant factors are mitigated by adverse signals in Long Upper Shadow, Long Lower Shadow, and Marubozu White. Technical forecast: cautious.
Analysis Checks(0/3)
Long Upper Shadow
Score1/10
Win Rate27.45%
Hist. Signals51
Avg Return-6.60%
Score1/10
Win Rate27.45%
Hist. Signals51
Avg Return-6.60%
Marubozu White
Score1/10
Win Rate36.36%
Hist. Signals22
Avg Return-2.09%
Score1/10
Win Rate36.36%
Hist. Signals22
Avg Return-2.09%
Long Lower Shadow
Score1/10
Win Rate35.82%
Hist. Signals67
Avg Return-3.64%
Score1/10
Win Rate35.82%
Hist. Signals67
Avg Return-3.64%
Long Upper Shadow
Score1/10
Win Rate27.45%
Hist. Signals51
Avg Return-6.60%
Score1/10
Win Rate27.45%
Hist. Signals51
Avg Return-6.60%
Long Lower Shadow
Score1/10
Win Rate35.82%
Hist. Signals67
Avg Return-3.64%
Score1/10
Win Rate35.82%
Hist. Signals67
Avg Return-3.64%
Marubozu White
Score1/10
Win Rate36.36%
Hist. Signals22
Avg Return-2.09%
Score1/10
Win Rate36.36%
Hist. Signals22
Avg Return-2.09%
What is the current technical signals for CMND?
- CMND presents a Underperform setup with a Technical Score of 1.00/10. Key technical indicators highlight an RSI of 22.41 and a MACD of 0.17, with the trend anchored by the 50-Day SMA at 3.04. Traders should monitor key support at 1.23 and resistance at 1.76.
